Zobrazeno 1 - 1
of 1
pro vyhledávání: '"L.A. Cancel-Treviño"'
Nivolumab and ipilimumab in the treatment of metastatic renal cell carcinoma. Report of two patients
Publikováno v:
Medicina Universitaria. 19:22-26
In recent years new therapies have emerged for the management of metastatic renal cell carcinoma, from agents directed to the inhibition of the vascular endothelial growth factor (VEGF) pathway and mammalian target of rapamycin (mTOR) to novel immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95c556d1e052c0724346c4c072f82584
https://doi.org/10.1016/j.rmu.2017.02.003
https://doi.org/10.1016/j.rmu.2017.02.003
